{"database": "openregs", "table": "documents", "rows": [["FDA-2015-D-3517-0001", "FDA", "FDA-2015-D-3517", "Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Draft Guidance; Availability", "Notice", "Notice of Availability", "2015-10-27T04:00:00Z", 2015, 10, "2015-10-27T04:00:00Z", "2015-12-29T04:59:59Z", "2015-12-29T22:01:04Z", "2015-27269", 0, 0, "0900006481cf151f"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2015-D-3517-0001"], "units": {}, "query_ms": 0.35113003104925156, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}